ABN AMRO Investment Solutions’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163M Buy
649,098
+411,780
+174% +$88.6M 1.42% 14
2026
Q1
$51.6M Buy
237,318
+105,906
+81% +$23.5M 0.67% 36
2025
Q4
$30M Buy
131,412
+68,656
+109% +$15.6M 0.44% 47
2025
Q3
$14.5M Sell
62,756
-5,108
-8% -$1.04M 0.3% 72
2025
Q2
$12.6M Sell
67,864
-6,171
-8% -$1.15M 0.25% 80
2025
Q1
$15.5M Sell
74,035
-80,892
-52% -$15.7M 0.32% 68
2024
Q4
$27.5M Sell
154,927
-11,741
-7% -$2.16M 0.51% 53
2024
Q3
$32.9M Buy
166,668
+12,252
+8% +$2.29M 0.57% 51
2024
Q2
$26.5M Sell
154,416
-343
-0.2% -$56.8K 0.48% 56
2024
Q1
$28.2M Buy
154,759
+146,647
+1,808% +$25.3M 0.49% 55
2023
Q4
$1.26M Sell
8,112
-234
-3% -$34.1K 0.02% 289
2023
Q3
$1.24M Buy
8,346
+1,044
+14% +$153K 0.02% 281
2023
Q2
$984K Sell
7,302
-2,865
-28% -$420K 0.02% 285
2023
Q1
$1.62M Buy
+10,167
New +$1.55M 0.03% 268

Other funds holding ABBV

ABN AMRO Investment Solutions's ABBV Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its AbbVie (ABBV) stake by 174% in Q2 2026, buying an estimated $88.6M and bringing the position to 649,098 shares worth $163M. The position accounts for 1.42% of the portfolio, ranked #14.

ABN AMRO Investment Solutions first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ABN AMRO Investment Solutions held 649,098 shares of AbbVie worth $163M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 411,780 AbbVie shares in Q2 2026, an estimated $88.6M.
  • AbbVie made up 1.42% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #14 holding.
  • ABN AMRO Investment Solutions first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.